NACDS promotes Terry Arth to SVP of Member Services and Conferences
“Terry has been a visionary and disciplined leader in making NACDS meetings and conferences the gold standard in the industry,” said NACDS president and CEO Steven Anderson.
“Terry has been a visionary and disciplined leader in making NACDS meetings and conferences the gold standard in the industry,” said NACDS president and CEO Steven Anderson.
NovoCare Pharmacy provides direct-to-patient, convenient home shipments of all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients.
CONVERGENCE ‘25, on Oct. 9 – 10, brings industry professionals together for the main business conference, known for its thought-provoking and forward-looking topics, inspiring speakers, and the industry-defining discussions that take place.
Matrix Global Advisors report highlights current barriers and recommendations for robust competition and patient savings in the next decade.
CoverMyMeds' 2025 Medication Access Report: From Barriers to Bridges calls for increased collaboration and interoperability across the healthcare industry to improve patient outcomes.
Through this collaboration, NIQ Brandbank’s verified product data will integrate seamlessly with RangeMe’s platform.
"Tariffs on Canada and Mexico in particular risk destabilizing the North American economy," says RILA's Michael Hanson.
Target aims to elevate its product assortment with innovations and strategic partnerships as part of the plan.
As lawmakers prioritize health, CRN’s 2025 Day on the Hill will highlight the industry’s crucial role in offering safe, effective, science-backed nutrition products.
With latest transaction, Wellvana supports primary care providers across 40 states, serving approximately 1 million patients.
“Tariffs are just one tool at the administration’s disposal to achieve a secure border,” says NRF's David French.
In 2025, the number of people without commercial insurance coverage for these medications surged significantly. Zepbound saw a 14% increase since 2024, leaving 4.9 million people without coverage, and Ozempic saw a 22% increase, affecting another 1.1 million people.
“Our team grew traffic and delivered better-than-expected sales and profitability in our biggest quarter of the year,” said Target's CEO.
One webinar will explore practical strategies for managing stress, mastering self-care, and fostering a resilient, well-supported working environment.
Last year, the sold-out Show floor was filled with 1,821 exhibitors from 60 countries, including 700 first-time exhibitors.
"We are encouraged by statements from President Trump and Speaker Johnson that the most damaging proposals regarding Medicaid have been taken off the table."